title: Fuchs' heterochromic iridocyclitis following bilateral ocular toxoplasmosis.
abstract: OBJECTIVE
  To describe the development of Fuchs' heterochromic iridocyclitis (FHI) following bilateral ocular toxoplasmosis in an Asian Indian female.
  
  
  METHODS
  Case report of a patient with bilateral ocular toxoplasmosis who developed bilateral Fuchs' heterochromic iridocyclitis.
  
  
  RESULTS
  Features characteristic of bilateral Fuchs' heterochromic iridocyclitis developed following several attacks of bilateral toxoplasmic retinochoroiditis in a 26-year-old Indian female patient.
  
  
  CONCLUSIONS
  Fuchs' heterochromic iridocyclitis can develop over a period of time in patients with ocular toxoplasmosis.
authors.affiliation: Medical and Vision Research Foundation, Sankara Nethralaya, Chennai, India. mrf@sankaranethralaya.org
authors.forename: Sudha K
authors.initials: SK
authors.lastname: Ganesh
authors.forename: Sumita
authors.initials: S
authors.lastname: Sharma
authors.forename: Kannan M
authors.initials: KM
authors.lastname: Narayana
authors.forename: Jyotirmay
authors.initials: J
authors.lastname: Biswas
mesh_terms: D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001284:Atrophy; D002981:Clindamycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015863:Iridocyclitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D007498:Iris / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D012008:Recurrence; D013411:Sulfadiazine / Q000627:therapeutic use; D014126:Toxoplasmosis, Ocular / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D000981:Antiprotozoal Agents; D013411:Sulfadiazine; D002981:Clindamycin; D011239:Prednisolone